Documents Design of the RESIST Study Program

Design of the RESIST Study Program Dr Kevin Curry Boehringer Ingelheim, Bracknell, UK Tipranavir Clinical Development Plan - Phase II-III Program 1182.52 Phase IIB 500/100…

Documents Design of the RESIST Study Program

Design of the RESIST Study Program Dr Kevin Curry Boehringer Ingelheim, Bracknell, UK Tipranavir Clinical Development Plan - Phase II-III Program 1182.52 Phase IIB 500/100…